Enthera
PrivateLast Round
Series A
Jan 28, 2021
Total Funding Raised
$47.1M
Company Overview
Enthera is a biopharmaceutical company that develops first-in-class biologics for the treatment of autoimmune disorders, including Type 1 Diabetes and Inflammatory Bowel Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enthera Comparables
Compare Enthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acelyrin | 74% | |
| EnteroTarget ApS | 71% | |
| Sanofi | 70% |
Enthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2021 | ||||
| Seed | Jul 24, 2018 | ||||
| Seed | Nov 23, 2016 | ||||
| Seed | Oct 1, 2016 |
Key People
Founding team and executive leadership
Enthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banca Profilo S.p.A. | Series A |
| Roche Venture Fund | Series A |
| Indaco Venture Partners SGR | Series A |
| AbbVie Ventures | Series A |
| Roche Venture Fund | Series A |
| JDRF | Seed, Series A |
| Sofinnova Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$42M round led by AbbVie Ventures, Roche Venture Fund, and Sofinnova Partners.
- Jul 24, 2018
$4.7M round led by Sofinnova Partners
Enthera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enthera's valuation, stock price, and market status.
Is Enthera a public or private company?
Enthera is a private company.
What is the current stock price of Enthera?
Enthera is a private company with no public stock price. No recent secondary market data is available.
How much is Enthera worth (valuation)?
Valuation information for Enthera is not publicly available.
Can I buy Enthera stock?
Enthera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enthera's last funding round?
Enthera's most recent funding round was Series A on January 28, 2021.
Who are the main investors in Enthera?
Key investors in Enthera include AbbVie Ventures, Roche Venture Fund, Sofinnova Partners.
Will Enthera IPO soon?
No public IPO plans have been announced for Enthera.
How can I track Enthera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enthera's secondary market activity and sign up for updates.